Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X Shares

144.96
+0.27000.19%
Post-market: 146.001.04+0.72%18:01 EDT
Volume:114.86K
Turnover:16.64M
Market Cap:202.94M
PE:- -
High:145.61
Open:144.71
Low:142.14
Close:144.69
52wk High:150.00
52wk Low:74.34
Shares:1.40M
Float Shares:1.40M
Volume Ratio:1.37
T/O Rate:8.20%
Dividend:1.26
Dividend Rate:0.87%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lilly Exec Says About 55% of Overall Zepbound Prescriptions are Self Pay

THOMSON REUTERS
·
Aug 05

Eli Lilly's Second-Quarter Results Beat Estimates, Company Raises Full-Year Revenue Guidance

Deep News
·
Aug 05

Eli Lilly Stock: the One Question in Otherwise Perfect Earnings and What it Means for Shares

Dow Jones
·
Aug 05

Lilly CFO Says Expects Global Rollout of Foundayo in All Major Markets in 2027

THOMSON REUTERS
·
Aug 05

Eli Lilly and Co Stock (LLY) Moved Up by 6.32% on Aug 5: A Full Analysis

TradingKey
·
Aug 05

Lilly Stock Jumps on Strong GLP-1 Sales

Dow Jones
·
Aug 05

Eli Lilly CFO Says Injectable Glp-1 Drugs Remain Key Growth Driver, Account for Three Out of Four New Patient Starts: Conf Call

THOMSON REUTERS
·
Aug 05

Eli Lilly Shares Surge Nearly 6% at Market Open

Deep News
·
Aug 05

Eli Lilly Lifts Annual Revenue Forecast After Blockbuster Drug Sales Surge Overseas

Deep News
·
Aug 05

Eli Lilly and Company Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Sector Update: Healthcare

MT Newswires Live
·
Aug 05

Eli Lilly Posts Q2 Revenue Growth Driven by Soaring GLP-1 Drug Demand

Deep News
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

U.S. Stocks on the MOVE-Arista Networks, CVS, Eli Lilly, Phillips 66

Reuters
·
Aug 05

US Stocks-S&P 500, Dow Futures Inch up as Mideast Hopes Offset SpaceX, AMD Drag

Reuters
·
Aug 05

Eli Lilly's second-quarter revenue hits $22.97 billion, surpassing expectations of $20.59 billion

Deep News
·
Aug 05

Eli Lilly's stock surges 6% in pre-market trading after strong Q2 earnings beat

Deep News
·
Aug 05

Weight Loss Drug Demand Surges, Eli Lilly's Q2 Revenue Soars 48% Year-Over-Year, Full-Year Guidance Raised to $85-87 Billion | Earnings Report

Deep News
·
Aug 05

Lilly's Revenue Soars 48%, Driven by Demand of Its GLP-1s

Dow Jones
·
Aug 05

Lilly Q2 Adjusted EPS USD 8.38 Vs. IBES Estimate USD 6.01

Reuters
·
Aug 05